Sign in
GBLX Stock Price, Chart, Stats & News
GB Sciences, Inc.
Save
GB Sciences, Inc. (GBLX) does not currently pay a dividend.
122,121
Market cap
–
Current P/E
–
Forward P/E
GBLX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals. The company specializes in crafting cannabinoid-inspired medications and complex therapeutic formulations intended for the prescription drug market. Its extensive intellectual property portfolio addresses a variety of medical conditions, with programs currently in pre-clinical animal stages.
Similar securities
Based on sector and market capitalization
Report issue